Skip to main content
. 2018 Aug 31;68(4):535–544. doi: 10.1093/cid/ciy540

Figure 3.

Figure 3.

Proportion of participants with neuropsychiatric adverse events in pre-specified categories. Abbreviations: DOR/3TC/TDF, doravirine at 100 mg, lamivudine at 300 mg, and tenofovir disoproxil fumarate at 300 mg; EFV/FTC/TDF, efavirenz at 600 mg, emtricitabine at 200 mg, and tenofovir disoproxil fumarate at 300 mg. *P < .001, †P = .033. aStatistical testing was not pre-specified for the secondary categories (depression and suicide/self-injury; psychosis and psychotic disorders).